EventsKBIOTTCatalyst eventSK Biopharmaceuticals Co Ltd (326030)From KRX Bio Technology Transfer Index (KBIOTT)Q2 2026 earnings release is scheduled.Korean translation2026년 2분기 실적 발표 예정됨.
